Novel methods for neural IgG characterization and validation in autoimmune neurologic disorders

Area of Science:

• Neurology
• Immunology
• Biotechnology

Background:

• Neural autoantibody testing is crucial for diagnosing autoimmune neurologic disorders.
• Over 50 disease-specific neural antibodies have been identified in the last 40 years.
• Traditional methods for antibody discovery are being enhanced by new technologies.

Purpose of the Study:

• To review traditional and novel methods for neural autoantibody discovery.
• To emphasize the role of protein array and phage immunoprecipitation sequencing (PhIP-Seq) in antibody discovery.
• To discuss the advantages, limitations, and future applications of these platforms in autoimmune neurology.

Main Methods:

• Review of existing literature on neural autoantibody discovery.
• Focus on immune-profiling assays: protein array and PhIP-Seq.
• Analysis of the integration of these novel methods into discovery workflows.

Main Results:

• The number of identified neural antibodies has grown substantially.
• Protein array and PhIP-Seq have expedited the discovery of new neural autoantibodies.
• These advanced techniques are key to identifying recent targets.

Conclusions:

• Protein array and PhIP-Seq represent significant advancements in neural autoantibody discovery.
• These platforms offer powerful tools for advancing autoimmune neurology research.
• Further exploration of these methods will likely yield more disease-specific antibodies.